Academic Journal
G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma
| العنوان: | G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma |
|---|---|
| المؤلفون: | Park, J.-W., Cheng, A.-L., Kudo, M., Park, J.H., Liang, P.-C., Hidaka, H., Izumi, N., Heo, J., Lee, Y.J., Sheen, I-S., Chiu, C.-F., Arioka, H., Morita, S., Arai, Y. |
| المصدر: | Journal of Hepatology ; volume 62, page S189-S190 ; ISSN 0168-8278 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2015 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s0168-8278(15)30007-6 |
| الاتاحة: | http://dx.doi.org/10.1016/s0168-8278(15)30007-6 https://api.elsevier.com/content/article/PII:S0168827815300076?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0168827815300076?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
| رقم الانضمام: | edsbas.CC021A9B |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s0168-8278(15)30007-6 |
|---|